Literature DB >> 11276089

Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights.

B O Villoutreix1, B Dahlbäck, D Borgel, S Gandrille, Y A Muller.   

Abstract

Protein S (PS) is a vitamin K-dependent glycoprotein that consists of several modules including a C-terminal sex hormone-binding globulin (SHBG)-like domain that has been subdivided into two laminin LG-type domains. The SHBG-like region of PS is known to bind to a complement regulator molecule, C4b-binding protein (C4BP), coagulation factor Va (FVa) and receptor tyrosine kinases. Inherited PS deficiency has been associated with thromboembolic disease. Yet, study of the mechanisms by which the SHBG-like region of PS serves its essential functions has so far been hampered because of the lack of structural information. Recently, the three-dimensional (3D) structure of LG domains from plasma SHBG, laminin and neurexin have been reported and were found related to the pentraxin family. We used these X-ray structures to build homology models of the SHBG-like region of human PS. We then analyzed previously reported experimental/clinical data in the light of the predicted structures. A potential calcium-binding site is found in the first LG domain of PS and D292 could play a role in this process. This region is close to the interface between the two LG domains and is also surrounded by segments that have been suggested by synthetic peptide studies to be important for C4BP or FVa binding. The 39 point mutations linked to PS deficiencies or reported as neutral variants were rationalized in the 3D structure. Proteins 2001;43:203-216. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276089

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

1.  Compound heterozygous mutations in the PROS1 gene responsible for quantitative and qualitative protein S deficiency.

Authors:  Jun Yamanouchi; Takaaki Hato; Tatsushiro Tamura; Hiroshi Fujiwara; Yoshihiro Yakushijin; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2009-10-14       Impact factor: 2.490

Review 2.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

3.  The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling.

Authors:  Nour Al Kafri; Josefin Ahnström; Adrienn Teraz-Orosz; Ludovic Chaput; Natesh Singh; Bruno O Villoutreix; Sassan Hafizi
Journal:  Biochem Biophys Rep       Date:  2022-04-28

4.  Role of the PROS1 gene in thrombosis: lessons and controversies.

Authors:  Mary J Heeb
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

5.  Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.

Authors:  Mary J Heeb; Duane Prashun; John H Griffin; Bonno N Bouma
Journal:  FASEB J       Date:  2009-02-24       Impact factor: 5.191

6.  Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Authors:  Adrienn Teraz-Orosz; Magdalena Gierula; Anastasis Petri; David Jones; Renos Keniyopoullos; Patricia Badia Folgado; Salvatore Santamaria; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood Adv       Date:  2022-01-25

7.  TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Authors:  Natalia Reglińska-Matveyev; Helena M Andersson; Suely M Rezende; Björn Dahlbäck; James T B Crawley; David A Lane; Josefin Ahnström
Journal:  Blood       Date:  2014-04-16       Impact factor: 22.113

8.  Streptococcal pyrogenic exotoxin B inhibits apoptotic cell clearance by macrophages through protein S cleavage.

Authors:  Chia-Ling Chen; Yueh-Ying Wu; Chiou-Feng Lin; Chih-Feng Kuo; Chia-Li Han; Shuying Wang; Woei-Jer Chuang; Chiu-Yueh Chen; Jiunn-Jong Wu; Pei-Jane Tsai; Ching-Chuan Liu; Yee-Shin Lin
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.